International multicenter study to assess a panel of reference materials for quantification of Simian immunodeficiency virus RNA in plasma

Journal of Clinical Microbiology

Volumn 48, Issue 7, 2010, Pages 2582-2585

  Ham, Claire ^a   Srinivasan, Priya ^b   Thorstensson, Rigmor ^c   Verschoor, Ernst ^d   Fagrouche, Zahra ^d   Sernicola, Leonardo ^e   Ramos, Artur ^b   Titti, Fausto ^e   Almond, Neil ^a   Berry, Neil ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c SIIDC   (Sweden)

^d BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^e ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; BLOOD LEVEL; MACACA; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA REPLICATION; SIMIAN IMMUNODEFICIENCY VIRUS; VIRION; VIRUS DETECTION; VIRUS LOAD; ANIMAL; BLOOD; CLINICAL TRIAL; GENETICS; ISOLATION AND PURIFICATION; MACACA FASCICULARIS; MULTICENTER STUDY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARD; STANDARDS; STATISTICAL MODEL; VIROLOGY;

SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; LINEAR MODELS; MACACA FASCICULARIS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 77954440002     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00082-10     Document Type: Article

References (30)

1. Berry, N., R. Stebbings, D. Ferguson, C. Ham, J. Alden, S. Brown, A. Jenkins, A. Clayton, J. Lines, L. Davis, M. Page, R. Hull, J. Stott, and N. Almond. 2008. Resistance to superinfection of a vigorously replicating, uncloned stock of simian immunodeficiency virus (SIVmac251) stimulates replication of a live attenuated virus vaccine (SIVmacC8). J. Gen. Virol. 89: 2240-2251.
2. Clarke, S., N. Almond, and N. Berry. 2003. Simian immunodeficiency virus nef gene regulates the production of 2-LTR circles in vivo. Virology 306: 100-108.
3. Corrigan, G. E., E. Hansson, A. Mörner, N. Berry, C. Källander, and R. Thorstensson. 2006. Reverse transcriptase viral load correlates with RNA in SIV/SHIV infected macaques. AIDS Res. Hum. Retroviruses 22:917-923.
4. Damond, F., A. Benard, J. Ruelle, A. Alabi, B. Kupfer, P. Gomes, B. Rodes, J. Albert, J. Boni, J. Garson, B. Ferns, S. Matheron, G. Chene, and F. Brun-Vezinet for the ACHIEV2E (a Collaboration on HIV-2 Infection) Study Group. 2008. Quality control assessment of human immunodeficiency virus type 2 (HIV-2) viral load quantification assays: results from an international collaboration on HIV-2 infection in 2006. J. Clin. Microbiol. 46:2088-2091.
5. Goletti, D., I. Macchia, P. Leone, M. Pace, L. Sernicola, M. R. Pavone-Cossut, M. T. Maggiorella, A. Cafaro, B. Ensoli, and F. Titti. 2006. Innate anti-viral immunity is associated with the protection elicited by the simian immunodeficiency virus (SIV) live attenuated virus vaccine in cynomolgus monkeys. Med. Sci. Monit. 12:330-340.
6. Hahn, B. H., G. M. Shaw, K. M. De Cock, and P. M. Sharp. 2000. AIDS as a zoonosis: scientific and public health implications. Science 287:607-614.
7. Hessell, A. J., E. G. Rakasz, D. M. Tehrani, M. Huber, K. L. Weisgrau, G. Landucci, D. N. Forthal, W. C. Koff, P. Poignard, D. I. Watkins, and D. R. Burton. 2010. Broadly neutralizing monoclonal antibodies 2F5 and 4E10 directed against the human immunodeficiency virus type 1 gp41 membrane-proximal external region protect against mucosal challenge by simian-human immunodeficiency virus SHIVBa-L. J. Virol. 84:1302-1313.
8. Hirsch, V. M., T. R. Fuerst, G. Sutter, M. W. Carroll, L. C. Yang, S. Goldstein, M. Piatek, W. R. Elkins, W. G. Alvord, D. C. Montefiori, B. Moss, and J. D. Lifson. 1996. Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. J. Virol. 70:3741-3752.
9. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markovitz. 1995. Rapid turnover of plasma viraemia and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126.
10. Hoffmann-Lehman, R., R. K. Swenerton, V. Liska, C. M. Leutenegger, H. Lutz, H. M. McClure, and R. M. Ruprecht. 2000. Sensitive and robust one-tube real-time reverse transcriptase-polymerase chain reaction to quantify SIV RNA load: comparison of one-versus two-enzyme systems. AIDS Res. Hum. Retroviruses 16:1247-1257.
11. Koff, W. C., P. R. Johnson, D. I. Watkins, D. R. Burton, J. D. Lifson, K. J. Hasenkrug, A. B. McDermott, A. Schultz, T. J. Zamb, R. Boyle, and R. C. Desrosiers. 2006. HIV vaccine design: insights from live attenuated SIV vaccines. Nat. Immunol. 7:19-23.
12. Leutenegger, C. M., J. Higgins, T. B. Matthews, A. F. Tarantal, P. A. Luciw, N. C. Pedersen, and T. W. North. 2001. Real-time TaqMan PCR as a specific and more sensitive alternative to the branched-chain DNA assay for the quantification of simian immunodeficiency virus RNA. AIDS. Res. Hum. Retroviruses 17:243-251.
13. Lifson, J. D., M. A. Nowak, S. Goldstein, J. L. Rossio, A. Kinter, G. Vasquez, T. A. Wiltrout, C. Brown, D. Schneider, L. Wahl, A. L. Lloyd, J. Williams, W. R. Elkins, A. S. Fauci, and V. M. Hirsch. 1997. The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection. J. Virol. 71:9508-9514.
14. Mellors, J. W., C. R. Rinaldo, P. Gupta, R. M. White, J. A. Todd, and L. A. Kingsley. 1996. Prognosis of HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170.
15. Morgan, C., M. Marthas, C. Miller, A. Duerr, C. Cheng-Mayer, R. Desrosiers, J. Flores, N. Haigwood, S. L. Hu, R. P. Johnson, J. Lifson, D. Montefiori, J. Moore, M. Robert-Guroff, H. Robinson, S. Self, and L. Corey. 2008. The use of nonhuman primate models in HIV vaccine development. PLoS Med. 5:e173.
16. Morris, C., N. Berry, A. Heath, and H. Holmes. 2008. An international collaborative study to establish a replacement WHO international standard for HIV-1 RNA nucleic acid assays. Vox Sang. 95:218-225.
17. Muyldermans, G., L. Debaisieux, K. Fransen, D. Marissens, K. Miller, D. Vaira, A. M. Vandamme, A. T. Vandenbroucke, C. Verhofstede, R. Schuurman, G. Zissis, and S. Lauwers. 2000. Blinded, multicenter quality control study for the quantification of human immunodeficiency virus type 1 RNA in plasma by the Belgian AIDS reference laboratories. Clin. Microbiol. Infect. 6:213-217.
18. Negri, D. R., S. Baroncelli, S. Catone, A. Comini, Z. Michelini, M. T. Maggiorella, L. Sernicola, F. Crostarosa, R. Belli, M. G. Mancini, S. Farcomeni, Z. Fagrouch, M. Ciccozzi, S. Boros, P. Liljestrom, S. Norley, J. Heeney, and F. Titti. 2004. Protective efficacy of a multicomponent vector vaccine in cynomolgus monkeys after intrarectal simian immunodeficiency virus challenge. J. Gen. Virol. 85:1191-1201.
19. Piatek, M., Jr., M. S. Saag, L. C. Yang, S. J. Clark, J. C. Kappes, K. C. Luk, B. Hahn, G. M. Shaw, and J. D. Lifson. 1993. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259: 1749-1754.
20. Promadej-Lanier, N., P. Srinivasan, K. Curtis, D. R. Adams, C. Kim, W. Luo, H. Jia, S. Subbarao, R. A. Otten, and S. Butera. 2008. Systemic and mucosal immunological responses during repeated mucosal SHIV(162P3) challenges prior to and following infection in pigtailed macaques. Virology 375:492-503.
21. Schuurman, R., D. Descamps, G. Jan Weverling, S. Kaye, J. Tinjnagel, I. Williams, R. van Leeuwen, R. Tedder, C. Boucher, F. Brun-Vezinet, and C. Loveday. 1996. Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 34:3016-3022.
22. Staprans, S., P. J. Dailey, A. Rosenthal, C. Horton, R. M. Grant, N. Lerche, and M. B. Feinberg. 1999. Simian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection. J. Virol. 73:4829-4839. (Pubitemid 29246743)
23. Subbarao, S., A. Ramos, C. Kim, D. Adams, M. Monsour, S. Butera, T. Folks, and R. A. Otten. 2007. Direct stringency comparison of two macaque models (single-high vs. repeat-low) for mucosal HIV transmission using an identical anti-HIV chemoprophylaxis intervention. J. Med. Primatol. 36:238-243.
24. Subbarao, S., R. A. Otten, A. Ramos, C. Kim, E. Jackson, M. Monsour, D. R. Adams, S. Bashirian, J. Johnson, V. Soriano, A. Rendon, M. G. Hudgens, S. Butera, R. Janssen, L. Paxton, A. E. Greenberg, and T. M. Folks. 2006. Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges. J. Infect. Dis. 194:904-911.
25. Suryanarayana, K., T. A. Wiltrout, G. M. Vasquez, V. M. Hirsch, and J. D. Lifson. 1998. Plasma SIV RNA load determination by real-time quantification of product generation in reverse transcriptase polymerase chain reaction. AIDS Res. Hum. Retroviruses 14:183-189.
26. Swanson, P., V. Soriano, S. G. Devare, and J. Hackett, Jr. 2001 Comparative performance of three viral load assays on human immunodeficiency virus type 1 (HIV-1) isolates representing group M (subtypes A to G) and group O: LCx HIV RNA quantitative, AMPLICOR HIV-1 MONITOR version 1.5, and Quantiplex HIV-1 RNA version 3.0. J. Clin. Microbiol. 39:862-870.
27. ten Haaft, P., B. Verstrepen, K. Uberla, B. Rosenwirth, and J. Heeney. 1998. A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques. J. Virol. 72:10281-10285.
28. Van Heuverswyn, F., and M. Peeters. 2007. The origins of HIV and implications for the global epidemic. Curr. Infect. Dis. Rep. 9:338-346.
29. Wain, L. V., E. Bailes, F. Bibollet-Ruche, J. M. Decker, B. F. Keele, F. Van Heuverswyn, Y. Li, J. Takehisa, E. M. Ngole, G. M. Shaw, M. Peeters, B. H. Hahn, and P. M. Sharp. 2007. Adaptation of HIV-1 to its human host. Mol. Biol. Evol. 24:1853-1860.
30. Watson, A., J. Ranchalis, B. Travis, J. McClure, W. Sutton, P. R. Johnson, S. L. Hu, and N. L. Haigwood. 1997. Plasma viraemia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival. J. Virol. 71:284-290. (Pubitemid 26412290)